Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
The American Journal of Pathology|November 30, 2005
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cellsPaola Secchiero, Elisa Barbarotto, Arianna Gonelli, et al.
Biomolecules|January 28, 2026
Biological Evaluation and SAR Exploration of Bile Acid-Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal CancerDaniela Perrone, Elisabetta Melloni, Lorenzo Gnudi, et al.
Plos One|June 30, 2010
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenograftsPaola Secchiero, Sonia Zorzet, Claudio Tripodo, et al.
Oncotargets and Therapy|October 3, 2018
Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculatureStefania Gallo, Maria Vittoria Arcidiacono, Veronica Tisato, et al.
Plos One|June 28, 2012
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotypeVeronica Tisato, Giorgio Zauli, Rebecca Voltan, et al.
Plos One|December 24, 2011
Circulating TRAIL shows a significant post-partum decline associated to stressful conditionsGiorgio Zauli, Lorenzo Monasta, Erika Rimondi, et al.
Cells|August 28, 2024
circRNAs as Epigenetic Regulators of Integrity in Blood-Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple SclerosisElisabetta D'Aversa, Francesca Salvatori, Mauro Vaccarezza, et al.
Plos One|December 16, 2014
Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine modelVeronica Tisato, Chiara Garrovo, Stefania Biffi, et al.
Haematologica|June 13, 2012
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 statusGiorgio Zauli, Claudio Celeghini, Elisabetta Melloni, et al.
Oncotarget|December 30, 2014
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathwayChiara Agnoletto, Laura Brunelli, Elisabetta Melloni, et al.
Pageof 22